A Prospective Exploratory Clinical Study of Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Hypopharyngeal Carcinoma

Clinical trial NCT05940441 · RECRUITING

Trial details

NCT number: NCT05940441
Sponsor: Eye & ENT Hospital of Fudan University
Status: RECRUITING
Study type: OBSERVATIONAL

to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma

Start date: 2023-07-01
Primary completion: 2025-07-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.